Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- Real-world Study of AcalabrutinibEnrolling By Invitation
Sponsor: Ruijin Hospital
Mantle Cell Lymphoma (MCL) · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
China
- A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsActive Not Recruiting
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer (NSCLC)
Hong Kong, Malaysia, Singapore, South Korea, Taiwan +1 more
Sponsor: AstraZeneca
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
United States, Australia, Canada, Turkey (Türkiye), United Kingdom
Sponsor: AstraZeneca
Non-small Cell Lung Cancer (NSCLC)
United States, Australia, Austria, Belgium, Brazil +16 more
Sponsor: AstraZeneca
Kidney Failure
United States
Sponsor: AstraZeneca
Moderate-to-Severe Asthma
China
- A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical PracticeActive Not Recruiting
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Austria, Belgium, Canada, France, Germany +4 more
- Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk Using Artificial IntelligenceNot Yet Recruiting
Sponsor: AstraZeneca
Lung Cancer
Brazil
Sponsor: AstraZeneca
Dilated Cardiomyopathy
Netherlands
Sponsor: Memorial Sloan Kettering Cancer Center
Lung Cancer Screening
United States
- Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCLRecruiting
Sponsor: AstraZeneca
Diffuse Large B-Cell Lymphoma
United States, Brazil, Puerto Rico, South Korea, Taiwan
- A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing TumorsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
China
- CLL Therapy Approaches in RussiaActive Not Recruiting
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia
Russia
Sponsor: AstraZeneca
Gynaecological Cancers
Brazil
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Australia, Brazil, Canada, China +15 more
- Adding Capivasertib to Standard Treatment in HR Positive, HER2 Negative Metastatic Breast Cancer Based on ctDNA TestingNot Yet Recruiting
Sponsor: SWOG Cancer Research Network
HR Positive/HER-2 Negative Breast Cancer
- Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's MacroglobulinemiaActive Not Recruiting
Sponsor: Sunnybrook Health Sciences Centre
Waldenstrom Macroglobulinemia
Canada
Sponsor: AstraZeneca
Lung Neoplasms
Canada
Sponsor: AstraZeneca
Endometrial Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
Sponsor: Tempus AI
Head and Neck Squamous Cell Carcinoma
United States, Puerto Rico
Sponsor: AstraZeneca
Severe Eosinophilic Asthma
China
Sponsor: AstraZeneca
Lung Cancer · Breast Cancer
Brazil, Kenya
Sponsor: Yale University
Breast Cancer Metastatic
United States
Sponsor: AstraZeneca
Locally Advanced Head and Neck Squamous Cell Carcinoma
United States, Austria, Belgium, Brazil, Canada +18 more
Sponsor: AstraZeneca
Severe Asthma
China